[Study on transcatheter embolization for renal carcinoma. 3rd Report--bioavailability of anti-cancer agent (adriamycin) administered during transcatheter embolization (author's transl)].
D000818:Animals; D001682:Biological Availability; D002404:Catheterization; D004317:Doxorubicin / Q000008:administration & dosage / Q000378:metabolism*; D004621:Embolization, Therapeutic / Q000379:methods*; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007680:Kidney Neoplasms / Q000378:metabolism* / Q000628:therapy; D007700:Kinetics; D008297:Male; D051381:Rats
D004317:Doxorubicin